2025-2031 Global Clinical Irreversible Electroporation Equipment Industry Research & Trends Analysis Report- YH Research

Home > Reports >Medical Devices & Consumables > 2025-2031 Global Clinical Irreversible Electroporation Equipment Industry Research & Trends Analysis Report

2025-2031 Global Clinical Irreversible Electroporation Equipment Industry Research & Trends Analysis Report

Publication Date: 2025-12-01
Report Id: 2858713
Industry: Medical Devices & Consumables
Report Page: 123
Chart: 129

PDF Download

Publication Date: 2025-12-01
Report Id: 2858713
Industry: Medical Devices & Consumables
Report Page: 123
Chart: 129

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Clinical Irreversible Electroporation Equipment Definition
1.2 Global Clinical Irreversible Electroporation Equipment Market Size and Forecast
1.2.1 By Revenue, Global Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
1.2.2 By Sales Volume, Global Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
1.2.3 Global Clinical Irreversible Electroporation Equipment Price Trend, 2020-2031
1.3 China Clinical Irreversible Electroporation Equipment Market Size and Forecast
1.3.1 By Revenue, China Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
1.3.2 By Sales Volume, China Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
1.3.3 China Clinical Irreversible Electroporation Equipment Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Clinical Irreversible Electroporation Equipment Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Clinical Irreversible Electroporation Equipment Share in Global Market, 2020-2031
1.4.3 Clinical Irreversible Electroporation Equipment Market Size: China VS Global, 2020-2031
1.5 Clinical Irreversible Electroporation Equipment Market Dynamics
1.5.1 Clinical Irreversible Electroporation Equipment Market Drivers
1.5.2 Clinical Irreversible Electroporation Equipment Market Restraints
1.5.3 Clinical Irreversible Electroporation Equipment Industry Trends
1.5.4 Clinical Irreversible Electroporation Equipment Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Clinical Irreversible Electroporation Equipment Revenue by Company, 2020-2025
2.2 Global Clinical Irreversible Electroporation Equipment Sales Volume by Company, 2020-2025
2.3 Global Clinical Irreversible Electroporation Equipment Price by Company, 2020-2025
2.4 Global Clinical Irreversible Electroporation Equipment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Clinical Irreversible Electroporation Equipment Concentration Ratio
2.6 Global Clinical Irreversible Electroporation Equipment Mergers & Acquisitions, Expansion Plans
2.7 Global Clinical Irreversible Electroporation Equipment Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Clinical Irreversible Electroporation Equipment Revenue by Company, 2020-2025
3.2 China Clinical Irreversible Electroporation Equipment Sales Volume by Company, 2020-2025
3.3 China Clinical Irreversible Electroporation Equipment Clinical Irreversible Electroporation Equipment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Clinical Irreversible Electroporation Equipment Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Clinical Irreversible Electroporation Equipment Domestic VS Export
3.6 China Market, Clinical Irreversible Electroporation Equipment Import & Export
3.6.1 China Market, Clinical Irreversible Electroporation Equipment Import & Export, 2020-2031
3.6.2 China Clinical Irreversible Electroporation Equipment Import & Export Trends
3.6.3 Main Sources of China Clinical Irreversible Electroporation Equipment Import
3.6.4 Export Destination of China Clinical Irreversible Electroporation Equipment

4 Clinical Irreversible Electroporation Equipment Production by Region
4.1 Global Clinical Irreversible Electroporation Equipment Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Clinical Irreversible Electroporation Equipment Manufacturers
4.3 Global Major Manufacturers, Clinical Irreversible Electroporation Equipment Capacity Expansion and Future Plans
4.4 Global Clinical Irreversible Electroporation Equipment Capacity by Region
4.5 Global Clinical Irreversible Electroporation Equipment Production by Region
4.5.1 Global Clinical Irreversible Electroporation Equipment Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Clinical Irreversible Electroporation Equipment Production by Region, 2020-2025
4.5.3 Global Clinical Irreversible Electroporation Equipment Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Clinical Irreversible Electroporation Equipment Industry Chain
5.2 Clinical Irreversible Electroporation Equipment Upstream Analysis
5.2.1 Clinical Irreversible Electroporation Equipment Core Raw Materials
5.2.2 Main Manufacturers of Clinical Irreversible Electroporation Equipment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Clinical Irreversible Electroporation Equipment Production Mode
5.6 Clinical Irreversible Electroporation Equipment Procurement Model
5.7 Clinical Irreversible Electroporation Equipment Industry Sales Model and Sales Channels
5.7.1 Clinical Irreversible Electroporation Equipment Sales Model
5.7.2 Clinical Irreversible Electroporation Equipment Typical Distributors

6 Sights by Type
6.1 Clinical Irreversible Electroporation Equipment Classification by Type
6.1.1 Pulse Power Generator
6.1.2 Electrode Probe
6.2 by Type, Global Clinical Irreversible Electroporation Equipment Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Clinical Irreversible Electroporation Equipment Revenue, 2020-2031
6.4 by Type, Global Clinical Irreversible Electroporation Equipment Sales Volume, 2020-2031
6.5 by Type, Global Clinical Irreversible Electroporation Equipment Price, 2020-2031

7 Sights by Device Grade
7.1 Clinical Irreversible Electroporation Equipment Classification by Device Grade
7.1.1 Microsecond Level
7.1.2 Nanosecond Level
7.2 by Device Grade, Global Clinical Irreversible Electroporation Equipment Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Device Grade, Global Clinical Irreversible Electroporation Equipment Revenue, 2020-2031
7.4 by Device Grade, Global Clinical Irreversible Electroporation Equipment Sales Volume, 2020-2031
7.5 by Device Grade, Global Clinical Irreversible Electroporation Equipment Price, 2020-2031

8 Sights by Tumor Types
8.1 Clinical Irreversible Electroporation Equipment Classification by Tumor Types
8.1.1 Pancreatic Cancer
8.1.2 Prostate Cancer
8.1.3 Liver Cancer
8.1.4 Other
8.2 by Tumor Types, Global Clinical Irreversible Electroporation Equipment Market Size & CAGR, 2020 VS 2024 VS 2031
8.3 by Tumor Types, Global Clinical Irreversible Electroporation Equipment Revenue, 2020-2031
8.4 by Tumor Types, Global Clinical Irreversible Electroporation Equipment Sales Volume, 2020-2031
8.5 by Tumor Types, Global Clinical Irreversible Electroporation Equipment Price, 2020-2031

9 Sights by Form Factor
9.1 Clinical Irreversible Electroporation Equipment Classification by Form Factor
9.1.1 Mobile
9.1.2 Trolley-based
9.2 by Form Factor, Global Clinical Irreversible Electroporation Equipment Market Size & CAGR, 2020 VS 2024 VS 2031
9.3 by Form Factor, Global Clinical Irreversible Electroporation Equipment Revenue, 2020-2031
9.4 by Form Factor, Global Clinical Irreversible Electroporation Equipment Sales Volume, 2020-2031
9.5 by Form Factor, Global Clinical Irreversible Electroporation Equipment Price, 2020-2031

10 Sights by Application
10.1 Clinical Irreversible Electroporation Equipment Segment by Application
10.1.1 Hospitals
10.1.2 Clinics
10.2 by Application, Global Clinical Irreversible Electroporation Equipment Market Size & CAGR, 2020 VS 2024 VS 2031
10.3 by Application, Global Clinical Irreversible Electroporation Equipment Revenue, 2020-2031
10.4 by Application, Global Clinical Irreversible Electroporation Equipment Sales Volume, 2020-2031
10.5 by Application, Global Clinical Irreversible Electroporation Equipment Price, 2020-2031

11 Sales Sights by Region
11.1 By Region, Global Clinical Irreversible Electroporation Equipment Market Size, 2020 VS 2024 VS 2031
11.2 By Region, Global Clinical Irreversible Electroporation Equipment Revenue, 2020-2031
11.3 By Region, Global Clinical Irreversible Electroporation Equipment Sales Volume, 2020-2031
11.4 North America
11.4.1 North America Clinical Irreversible Electroporation Equipment Market Size & Forecasts, 2020-2031
11.4.2 By Country, North America Clinical Irreversible Electroporation Equipment Market Size Market Share
11.5 Europe
11.5.1 Europe Clinical Irreversible Electroporation Equipment Market Size & Forecasts, 2020-2031
11.5.2 By Country, Europe Clinical Irreversible Electroporation Equipment Market Size Market Share
11.6 Asia Pacific
11.6.1 Asia Pacific Clinical Irreversible Electroporation Equipment Market Size & Forecasts, 2020-2031
11.6.2 By Country/Region, Asia Pacific Clinical Irreversible Electroporation Equipment Market Size Market Share
11.7 South America
11.7.1 South AmericaClinical Irreversible Electroporation Equipment Market Size & Forecasts, 2020-2031
11.7.2 By Country, South America Clinical Irreversible Electroporation Equipment Market Size Market Share
11.8 Middle East & Africa

12 Sales Sights by Country Level
12.1 By Country, Global Clinical Irreversible Electroporation Equipment Market Size & CAGR，2020 VS 2024 VS 2031
12.2 By Country, Global Clinical Irreversible Electroporation Equipment Revenue, 2020-2031
12.3 By Country, Global Clinical Irreversible Electroporation Equipment Sales Volume, 2020-2031
12.4 United States
12.4.1 United States Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.4.2 By Company, United States Clinical Irreversible Electroporation Equipment Sales Volume Market Share, 2024
12.4.3 by Type, United States Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.4.4 by Application, United States Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.5 Europe
12.5.1 Europe Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.5.2 By Company, Europe Clinical Irreversible Electroporation Equipment Sales Volume Market Share, 2024
12.5.3 by Type, Europe Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.5.4 by Application, Europe Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.6 China
12.6.1 China Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.6.2 By Company, China Clinical Irreversible Electroporation Equipment Sales Volume Market Share, 2024
12.6.3 by Type, China Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.6.4 by Application, China Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.7 Japan
12.7.1 Japan Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.7.2 By Company, Japan Clinical Irreversible Electroporation Equipment Market Share, 2024
12.7.3 by Type, Japan Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.7.4 by Application, Japan Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.8 South Korea
12.8.1 South Korea Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.8.2 By Company, South Korea Clinical Irreversible Electroporation Equipment Market Share, 2024
12.8.3 by Type, South Korea Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.8.4 by Application, South Korea Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.9 Southeast Asia
12.9.1 Southeast Asia Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.9.2 By Company, Southeast Asia Clinical Irreversible Electroporation Equipment Market Share, 2024
12.9.3 by Type, Southeast Asia Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.9.4 by Application, Southeast Asia Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.10 India
12.10.1 India Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.10.2 By Company, India Clinical Irreversible Electroporation Equipment Market Share, 2024
12.10.3 by Type, India Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.10.4 by Application, India Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.11 Middle East & Africa
12.11.1 Middle East & Africa Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.11.2 By Company, Middle East & Africa Clinical Irreversible Electroporation Equipment Market Share, 2024
12.11.3 by Type, Middle East & Africa Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031
12.11.4 by Application, Middle East & Africa Clinical Irreversible Electroporation Equipment Market Size, Share, 2024 VS 2031

13 Manufacturers Profile
13.1 AngioDynamics
13.1.1 AngioDynamics Company Information, Head Office, Market Area, and Industry Position
13.1.2 AngioDynamics Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.1.3 AngioDynamics Clinical Irreversible Electroporation Equipment Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.1.4 AngioDynamics Company Profile and Main Business
13.1.5 AngioDynamics Recent Developments
13.2 IGEA
13.2.1 IGEA Company Information, Head Office, Market Area, and Industry Position
13.2.2 IGEA Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.2.3 IGEA Clinical Irreversible Electroporation Equipment Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.2.4 IGEA Company Profile and Main Business
13.2.5 IGEA Recent Developments
13.3 Surgnova
13.3.1 Surgnova Company Information, Head Office, Market Area, and Industry Position
13.3.2 Surgnova Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.3.3 Surgnova Clinical Irreversible Electroporation Equipment Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.3.4 Surgnova Company Profile and Main Business
13.3.5 Surgnova Recent Developments
13.4 Alpmed
13.4.1 Alpmed Company Information, Head Office, Market Area, and Industry Position
13.4.2 Alpmed Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.4.3 Alpmed Clinical Irreversible Electroporation Equipment Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.4.4 Alpmed Company Profile and Main Business
13.4.5 Alpmed Recent Developments
13.5 Shanghai Nortion Medical Technology
13.5.1 Shanghai Nortion Medical Technology Company Information, Head Office, Market Area, and Industry Position
13.5.2 Shanghai Nortion Medical Technology Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.5.3 Shanghai Nortion Medical Technology Clinical Irreversible Electroporation Equipment Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.5.4 Shanghai Nortion Medical Technology Company Profile and Main Business
13.5.5 Shanghai Nortion Medical Technology Recent Developments
13.6 Hangzhou Ready Biological Technology
13.6.1 Hangzhou Ready Biological Technology Company Information, Head Office, Market Area, and Industry Position
13.6.2 Hangzhou Ready Biological Technology Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.6.3 Hangzhou Ready Biological Technology Clinical Irreversible Electroporation Equipment Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.6.4 Hangzhou Ready Biological Technology Company Profile and Main Business
13.6.5 Hangzhou Ready Biological Technology Recent Developments

14 Conclusion

15 Appendix
15.1 Research Methodology
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Market Estimation Model
15.4 Disclaimer

According to YH Research, the global market for Clinical Irreversible Electroporation Equipment should grow from US$ 79.64 million in 2024 to US$ 116 million by 2031, with a CAGR of 5.3% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Clinical Irreversible Electroporation Equipment

According to YH Research, the global market for Clinical Irreversible Electroporation Equipment should grow from US$ 79.64 million in 2024 to US$ 116 million by 2031, with a CAGR of 5.3% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Clinical Irreversible Electroporation (IRE) equipment is a high-end minimally invasive therapeutic system that delivers non-thermal tumor ablation through steep pulsed electric fields. By placing multiple needle electrodes around the lesion and delivering high-voltage short pulses, the system induces permanent nanopores in cell membranes and triggers apoptosis, achieving precise ablation while preserving the structural integrity of surrounding tissues. A typical system integrates a high-voltage pulse generator, pulse-modulation unit, multi-channel electrode interface, disposable or reusable electrode sets, imaging-guided navigation modules, and workflow-oriented surgical software. Key upstream components include high-voltage electronic modules, medical-grade alloy electrodes, insulation-coating consumables, surgical-grade metallic materials, and imaging-based localization and control software. Downstream users include oncology hospitals, interventional departments of general hospitals, cancer centers, ambulatory surgery centers, and research institutions, with applications in solid-tumor ablation, electrophysiological interventions, minimally invasive dermatological procedures, and gene/cell-level experimental studies. In 2024, global production capacity is about 400 units, with approximately 223 units sold, an average selling price of USD 336,000 per system, and a gross margin of 40%–50%. Supported by the rapid maturation of non-thermal electric-field ablation technologies and rising demand for treating tumors in challenging anatomical locations, the market continues to expand steadily.

China Clinical Irreversible Electroporation Equipment market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

The United States Clinical Irreversible Electroporation Equipment market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

In terms of product type, Pulse Power Generator segment holds a share about % in 2024, and will reach % in 2031; while in terms of end use, Hospitals has a share approximately % in 2024, and will grow at a CAGR % during 2025 and 2031.

The global key manufacturers of Clinical Irreversible Electroporation Equipment include AngioDynamics, IGEA, Surgnova, Alpmed, Shanghai Nortion Medical Technology, Hangzhou Ready Biological Technology, etc. In 2024, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Clinical Irreversible Electroporation Equipment. 
Report Highlights:
(1) Global Clinical Irreversible Electroporation Equipment market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Clinical Irreversible Electroporation Equipment market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Clinical Irreversible Electroporation Equipment market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Clinical Irreversible Electroporation Equipment segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Clinical Irreversible Electroporation Equipment segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Clinical Irreversible Electroporation Equipment, capacity, production and trends.

(7) Clinical Irreversible Electroporation Equipment industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Pulse Power Generator
    Electrode Probe

Market segment by Device Grade, covers
    Microsecond Level
    Nanosecond Level

Market segment by Tumor Types, covers
    Pancreatic Cancer
    Prostate Cancer
    Liver Cancer
    Other

Market segment by Form Factor, covers
    Mobile
    Trolley-based

Market segment by Application, can be divided into
    Hospitals
    Clinics

Market segment by players, this report covers
    AngioDynamics
    IGEA
    Surgnova
    Alpmed
    Shanghai Nortion Medical Technology
    Hangzhou Ready Biological Technology